{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:11:37Z","timestamp":1783483897984,"version":"3.55.0"},"reference-count":9,"publisher":"FapUNIFESP (SciELO)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cad. Sa\u00fade P\u00fablica"],"published-print":{"date-parts":[[2012,3]]},"abstract":"<jats:p>O estudo analisa os gastos da judicializa\u00e7\u00e3o de medicamentos para a mucopolissacaridose (MPS), uma doen\u00e7a rara, de alto custo, fora da pol\u00edtica de assist\u00eancia farmac\u00eautica e com benef\u00edcio cl\u00ednico. O levantamento de dados foi realizado nos arquivos de 196 dossi\u00eas que determinou que o Minist\u00e9rio da Sa\u00fade fornecesse medicamentos no per\u00edodo entre 2006 e 2010, e nos registros administrativos e cont\u00e1beis do Minist\u00e9rio da Sa\u00fade. A an\u00e1lise identifica sujei\u00e7\u00e3o do governo brasileiro a monop\u00f3lios de distribui\u00e7\u00e3o de medicamentos e, consequentemente, perda de sua capacidade de administrar compras. Tamb\u00e9m identifica que a imposi\u00e7\u00e3o da aquisi\u00e7\u00e3o imediata e individualizada impede a obten\u00e7\u00e3o de economias de escala com a compra planejada de maiores quantidades de medicamento, e imp\u00f5e dificuldades log\u00edsticas para o controle das quantidades consumidas e estocadas. Conclui-se que a judicializa\u00e7\u00e3o decorre da aus\u00eancia de uma pol\u00edtica clara do sistema de sa\u00fade para doen\u00e7as raras em geral, e tem como consequ\u00eancia gastos acima do necess\u00e1rio para o tratamento.<\/jats:p>","DOI":"10.1590\/s0102-311x2012000300008","type":"journal-article","created":{"date-parts":[[2012,3,10]],"date-time":"2012-03-10T05:11:19Z","timestamp":1331356279000},"page":"479-489","source":"Crossref","is-referenced-by-count":41,"title":["Consequ\u00eancias da judicializa\u00e7\u00e3o das pol\u00edticas de sa\u00fade: custos de medicamentos para as mucopolissacaridoses"],"prefix":"10.1590","volume":"28","author":[{"given":"Debora","family":"Diniz","sequence":"first","affiliation":[{"name":"Instituto de Bio\u00e9tica Direitos Humanos e G\u00eanero,  Brasil; Universidade de Bras\u00edlia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Medeiros","sequence":"additional","affiliation":[{"name":"Universidade de Bras\u00edlia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Vanessa D.","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Hospital de Cl\u00ednicas de Porto Alegre,  Brasil; Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1590\/S0103-73312010000100006","article-title":"Judicializa\u00e7\u00e3o da sa\u00fade, acesso \u00e0 justi\u00e7a e \u00e0 efetividade do direito \u00e0 sa\u00fade","volume":"20","author":"Ventura M","year":"2010","journal-title":"Physis","ISSN":"https:\/\/id.crossref.org\/issn\/0103-7331","issn-type":"print"},{"issue":"4","key":"ref2","first-page":"S46","article-title":"A judicializa\u00e7\u00e3o da sa\u00fade e a pol\u00edtica nacional de assist\u00eancia farmac\u00eautica no Brasil: gest\u00e3o da cl\u00ednica e medicaliza\u00e7\u00e3o da justi\u00e7a","volume":"18","author":"Andrade E","year":"2008","journal-title":"Rev M\u00e9d Minas Gerais"},{"key":"ref3","series-title":"Ultra orphan drugs for lysosomal storage disorders","year":"2009"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/jme.2010.037150","article-title":"Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I","volume":"37","author":"Boy R","year":"2011","journal-title":"J Med Ethics","ISSN":"https:\/\/id.crossref.org\/issn\/0306-6800","issn-type":"print"},{"key":"ref5","series-title":"The metabolic and molecular basis of inherited disease","first-page":"3421","volume-title":"The mucopolysaccharidoses","author":"Neufeld E","year":"2001","edition":"7"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/ajmg.a.32320","article-title":"Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis?","volume":"146A","author":"Vieira T","year":"2008","journal-title":"Am J Med Genet","ISSN":"https:\/\/id.crossref.org\/issn\/0148-7299","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","article-title":"Enzyme replacement therapy for mucopolysaccharidosis IV: a phase 3, randomized, double-blind, placebo controlled, multinational study of recombinant human n-acetilgalactosamine 4-sulfatase (recombinant human arylsulfatase B or RHASB) and follow-on open label extension study","volume":"148","author":"Harmatz P","year":"2006","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer J","year":"2006","journal-title":"Genet Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis i: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-l-iduronidase (laronidase)","volume":"104","author":"Wraith JE","year":"2004","journal-title":"J Pediatr","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3476","issn-type":"print"}],"container-title":["Cadernos de Sa\u00fade P\u00fablica"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/csp\/v28n3\/08.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:44:05Z","timestamp":1495845845000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-311X2012000300008&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0102-311X2012000300008"],"URL":"https:\/\/doi.org\/10.1590\/s0102-311x2012000300008","relation":{},"ISSN":["0102-311X"],"issn-type":[{"value":"0102-311X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}